December 14 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its CEO Ognyan Donev acquired 11,647 shares in the company through deals priced at 3.12 levs ($1.94/1.60 euro) per share on December 11.